| Bid Price | 19.00p | High Price | 20.00p |
|---|
| Ask Price | 19.50p | Low Price | 17.50p |
|---|
| Open Price | 17.63p | Spread | 2.56% |
|---|
| Prev Close | 17.63p | Volume | 1,906,525 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 11, 2025 | 16.75 | 18.00 | 16.50 | 17.63 | 1,059,837 |
| Dec 10, 2025 | 17.00 | 18.50 | 16.50 | 16.75 | 2,533,786 |
| Dec 9, 2025 | 15.25 | 17.38 | 15.00 | 17.00 | 1,370,665 |
| Dec 8, 2025 | 14.50 | 16.00 | 14.00 | 15.25 | 985,116 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 113.66 m | Prev Close | 17.63p |
|---|
| PE Ratio | | Market Cap | £21.88 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.559651 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.803109 | Quick Ratio | 1.450777 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/07/25 | TIN | Colin Walsh | NED | 211,618 @ £0.00 | £0.00 |
| 11/07/25 | TIN | Colin Walsh | NED | 58,271 @ £0.00 | £0.00 |
| 12/05/25 | LOF | Simon Douglas | CH | 61,475 @ £0.06 | £3,750.00 |
| 12/05/25 | LOF | Colin Walsh | NED | 221,311 @ £0.06 | £13,500.00 |
| 12/05/25 | LOF | Matthew Baker | NED | 55,327 @ £0.06 | £3,375.00 |
| 06/05/25 | BUY | Adrian Kinkaid | CEO | 100,000 @ £0.06 | £6,180.00 |
| 22/10/24 | LOF | Simon Douglas | CH | 180,722 @ £0.04 | £7,500.00 |
| 22/10/24 | LOF | Colin Walsh | NED | 325,301 @ £0.04 | £13,500.00 |
| 22/10/24 | LOF | Matthew Baker | NED | 81,325 @ £0.04 | £3,375.00 |
| 16/10/24 | BUY | Adrian Kinkaid | CEO | 83,728 @ £0.04 | £3,504.00 |
Fusion Antibodies PLC News
